Susan D. DeVore - 19 Aug 2025 Form 4 Insider Report for Elevance Health, Inc. (ELV)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Aug 2025, 16:20:38 UTC
Prior SEC filing
23 May 2025
Next SEC filing
30 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kathleen S. Kiefer, Attorney in fact

Key filing fact

Susan D. DeVore filed Form 4 for Elevance Health, Inc. (ELV) on 21 Aug 2025.

Key facts

  • This page summarizes Susan D. DeVore's Form 4 filing for Elevance Health, Inc. (ELV).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 21 Aug 2025, 16:20.

Change

  • Previous filing in this sequence was filed on 23 May 2025.
  • Current net transaction value: +$374,580.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001587697 Primary reporting owner

DeVore Susan D.

Relationship
Director
Address
220 VIRGINIA AVENUE, INDIANAPOLIS
Signature
/s/ Kathleen S. Kiefer, Attorney in fact
Signature date
21 Aug 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ELV transaction

Common Stock

Purchase

Transaction value
$374,580
Shares
+1,200
Change %
+52%
Price
$312.15
Shares after
3,502
Date
19 Aug 2025
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

This transaction was executed in multiple purchases at prices ranging from $312.06 to $312.19. The price reported reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .